Concepedia

Publication | Open Access

First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor

73

Citations

28

References

2020

Year

Abstract

www.ClinicalTrials.gov code: NCT01618136.

References

YearCitations

Page 1